Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination

NCT07454369 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: A1: Etoricoxib / Betamethasone in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)
DRUG: A2: Etoricoxib (Arcoxia®, Laboratorios Schering-Plough, S.A. de C.V.)
DRUG: A3: Betamethasone (Celestone® Pediatric, Laboratorios Schering-Plough, S.A. de C.V.)

Sponsor

Laboratorios Silanes S.A. de C.V.